You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Summary of product characteristics

This link will take you to the electronic Medicines Compendium (eMC) website which is a non-GSK website.

View Summary of product of characteristics (GB)

View Summary of product characteristics (NI)

Patient information leaflet

This link will take you to the electronic Medicines Compendium (eMC) website which is a non-GSK website.

View Patient information leaflet (GB)

View Patient information leaflet (NI)

European public assessment report

Please see the European public assessment report. This link will take you to the European Medicines Agency website which is a non-GSK website.

View European public assessment report

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the Patient information leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store.
By reporting side effects you can help provide more information on the safety of this medicine.

Ambirix is a registered trademark of the GlaxoSmithKline Group of Companies